Introduction
Small ruminants have by tradition been regarded as farm or agricultural animals with very little connection with biomedical research and laboratory animal science (Rehbinder & Obrink 1997) . The use of small ruminants in biomedical research, however, has a long tradition and how to produce germ-free goats has been described already in 1913 by Kuster (see ]uhr 1976) . Since the late fifties, several reports on germ-free and gnotobiotic calves, sheep and goats have been published (]uhr 1976) .
Today the use of calves, sheep and goats in biomedical research is increasing. They may to a certain extent replace traditional laboratory animals, including dogs (FELASA 1998) , in the fields of surgery, genetics, physiology, transplantation techniques, endocrinology and bio-technology (Kuster 1913 , Tavernor et al. 1971 , Alexander et al. 1973 , Leader & Stark 1987 , Fowler et al. 1993 , Bruns et al. 1996 , Tulamo et al. 1996 , Pennisi et al. 1997 , Wilmut et al. 1997 . A large size is sometimes a crucial factor making the traditional laboratory animals (rodents and lagomorphs) less suited.
The health of an animal is always at risk from a variety of infections. Whether clinically manifest or not, infectious agents may produce effects that may impinge upon and change the outcome of experiments and treatments undertaken. Depending upon the specific infection, a variety of biological parameters may be affected such as behaviour, growth rate, relative organ weights, immune response, tumour development, etc. Subclinical infections can also lead to contamination of biological materials, tissue cultures, transplantable tumours and biological products. All infections, apparent or inapparent, are likely to increase biological variability. In addition, some animal infections are zoonotic, i.e. transmissible to man. For all these reasons, animal health monitoring programmes are important, adding to the reliability and reproducibility of research data and decreasing the risk for researchers and staff of contracting zoonotic infections.
These recommendations propose health monitoring programmes for small ruminants, defined as calves, sheep and goats, used in biomedical research, with the intention of harmonizing procedures and achieving similar standards of testing within the FELASA member countries. It is recognized that the wide variety in animal sources, husbandry practices, local and national animal health regulations and standards will lead to more variations in health status and monitoring requirements than encountered with common laboratory species such as rodents. A major goal of these recommendations is to ensure that health monitoring reports have a common standard and format, identifying the presence or absence of specific pathogens in laboratory animal colonies.
General considerations
1.1 Depending on local conditions, the number of agents to be monitored will vary from country to country. Diseases declared, by a national authority, to be absent in a certain country or region do not need to be monitored. Actual practice may exceed these recommendations in various ways, depending on local circumstances-for example the regional prevalence of specific organisms, the intended use of progeny or the existence of national monitoring schemes. Additional investigations may be deemed necessary. The results
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1.2 These recommendations are intended for the selection and purchase of small ruminants (e.g. calves, sheep and goatsl for use in biomedical research.
1.3 The specialized breeding of small ruminants for scientific purposes is an exception, and calves, sheep and goats are usually purchased from farms with traditional agricultural production. The standard and suitability of the premises on farms selected for the breeding of small ruminants intended for use in biomedical investigations, as well as the health of the animals being bred, must be regularly monitored (at least two visits/year) and the results recorded. All dead and aborted animals should be necropzied and the results incorporated in records kept for inspection.
1.4 These recommendations are also intended for experimental colonies and units where calves, sheep and goats are kept and used for biomedical research.
1.5 Each unit, farm or experimental colony being monitored is considered to be a separate microbiological entity. 
Inspection of the experimental animal unit
A clinical health monitoring programme shall be established under the direction of a veterinarian. All animals should be observed daily by an animal technician. Any signs of disease among the animals should be immediately reported to the veterinarian in charge. Animals with disease symptoms should be investigated by suitable diagnostic methods and in accordance with accepted veterinary practices. The presence of organisms and lesions listed in these recommendations and the results of clinical and pathological examinations should be included in the health monitoring report. Results obtained from other diagnostic investigations should be made available on request. Daily records should be kept for inspection. Before new animals are introduced either at the farm premises or at an experimental unit they should be kept separated and tested before they are put together with the other animals at the farm or unit.
Monitoring procedures

Laboratory investigations
All samples obtained from calves, sheep and goats in connection with routine health monitoring are to be taken from live animals. However, additional samples may be obtained from dead or euthanazed animals. Samples (bacteriology, serology, parasitology) are preferably monitored individually.
The screening programme
The number of animals monitored depends on the scope of the investigation and the total number of animals involved. At least four animals should be sampled. Frequency and sampling procedures should be in accordance with international standards or with the respective national disease control programmes and import/export regulations, but monitoring should occur at least once a year. Infectious diseases that do not need to be monitored for are:
• diseases which are already included and monitored in an official, national governmental screening programme (but the results should be included in the health monitoring report); • diseases officially declared absent in that country or region; • diseases for which the animals are vaccinated. In the latter case, special consideration should be given to clinical signs indicating the presence of such diseases.
Some agents are to be monitored on request or
• when associated with lesions;
• when associated with clinical signs of disease; • when there is evidence of perturbation of physiological or experimental parameters and/or breeding performance.
Health monitoring report
The main purpose of the health monitoring of experimental units is to supply investiga- 
General information on each report
The title of the report should be FELASAApproved Healtb Monitoring Report. This wording can only be used if the methods, frequency, sample size, species list of organisms monitored, and reporting are in full accordance with the recommendations published by FELASA. The design of the report can be changed, but only if it incorporates the data requested in the recommendations. At the top of each report should be: the identification of the breeder and the unit and the month and year when it was last re-stocked with the kind of species used. The introduction of animals of other ruminant species should also be mentioned (with the risk of cross-infection between animals of different speciesl, the date of the report, the date of sampling and testing of the animals, and the species and breed. In general the most appropriate and upto-date methods should be used.
Layout of the report with respect
Listing of pathogens, methods and names of monitoring laboratories
The organisms detailed in these recommendations should be listed alphabetically in their appropriate sections in the order: 1st section: viruses, including prions; 2nd section: bacteria, including mycoplasma, chlamydia, rickettsia and fungi; and 3rd section: parasites. Current accepted abbreviations for the pathogens may be used in the report. The full or abbreviated name of the laboratory carrying out the test must be recorded for each organism/agent, but where it is abbreviated the full name must be given at the bottom of the report. Where both a method and laboratory name are to be recorded, they should be in the order: microorganism, laboratory, method (FELASA1998). The results of special investigations of unusual or unexpected occurrences should be reported separately. 
Historical status of the farm(s}, for the colony(ies} and unit(s}
Additional information
Bacteria and fungi
Culturing is the method of choice unless otherwise stated. Bacteriological investigations must always include the use of non-selective, as well as of selective, media. Serological methods exists for the detection of antibodies to various pathogens.
Other recognized and validated methods may be used.
Samples to be investigated
Samples from the following sites must be cultured: nose, tonsillary region (swab), preputium/vagina and faeces (fresh material collected by a suitable method) and milk in lactating sheep and goat. If the presence of resistant bacteria strains or new or uncommon resistance patterns are found they should be reported. 
Parasites
